ORBIMED ADVISORS LLC Q2 2017 Filing
Filed August 14, 2017
Portfolio Value
$9.5B
Holdings
135
Report Date
Q2 2017
Filing Type
13F-HR
All Holdings (135 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALXNALEXION PHARMACEUTICALS INC | 3,871,786 | $471.1B | 4937.75% | |
| 2 | CELGCELGENE CORP | 3,425,777 | $444.9B | 4663.40% | |
| 3 | BIIBBIOGEN INC | 1,630,000 | $442.3B | 4636.26% | |
| 4 | BSXBOSTON SCIENTIFIC CORP | 14,400,000 | $399.2B | 4183.98% | |
| 5 | MRKMERCK & CO INC | 5,487,000 | $351.7B | 3686.04% | |
| 6 | VRTXVERTEX PHARMACEUTICALS INC | 2,026,502 | $261.2B | 2737.36% | |
| 7 | LLYLILLY ELI & CO | 3,075,000 | $253.1B | 2652.65% | |
| 8 | —WRIGHT MED GROUP N V | 8,946,234 | $245.9B | 2577.80% | |
| 9 | REGNREGENERON PHARMACEUTICALS | 466,770 | $229.2B | 2402.93% | |
| 10 | AG8AGILENT TECHNOLOGIES INC | 3,814,100 | $226.2B | 2371.12% | |
| 11 | AMGNAMGEN INC | 1,302,700 | $224.4B | 2351.73% | |
| 12 | EWEDWARDS LIFESCIENCES CORP | 1,839,300 | $217.5B | 2279.56% | |
| 13 | PBYIPUMA BIOTECHNOLOGY INC | 2,425,735 | $212.0B | 2222.23% | |
| 14 | INCYINCYTE CORP | 1,663,400 | $209.4B | 2195.29% | |
| 15 | CICIGNA CORPORATION | 1,222,100 | $204.6B | 2144.22% | |
| 16 | CLVSEURCLOVIS ONCOLOGY INC | 2,104,370 | $197.0B | 2065.24% | |
| 17 | HUMHUMANA INC | 770,900 | $185.5B | 1944.30% | |
| 18 | ELVANTHEM INC | 920,618 | $173.2B | 1815.40% | |
| 19 | ABBVABBVIE INC | 2,197,600 | $159.3B | 1670.25% | |
| 20 | JNJJOHNSON & JOHNSON | 1,124,400 | $148.7B | 1559.13% | |
| 21 | GILDGILEAD SCIENCES INC | 2,073,400 | $146.8B | 1538.25% | |
| 22 | —LOXO ONCOLOGY INC | 1,728,000 | $138.6B | 1452.44% | |
| 23 | —AETNA INC NEW | 887,900 | $134.8B | 1413.05% | |
| 24 | ARRYEURARRAY BIOPHARMA INC | 14,182,900 | $118.7B | 1244.30% | |
| 25 | —MYLAN N V | 2,979,200 | $115.7B | 1212.25% | |
| 26 | IRWDIRONWOOD PHARMACEUTICALS INC | 5,759,200 | $108.7B | 1139.72% | |
| 27 | ICPTUSDINTERCEPT PHARMACEUTICALS IN | 856,554 | $103.7B | 1086.99% | |
| 28 | JAZZJAZZ PHARMACEUTICALS PLC | 645,900 | $100.4B | 1052.76% | Call |
| 29 | AERIEURAERIE PHARMACEUTICALS INC | 1,831,647 | $96.3B | 1008.90% | |
| 30 | —SYNERGY PHARMACEUTICALS DEL | 21,153,343 | $94.1B | 986.67% | |
| 31 | ASNDASCENDIS PHARMA A S | 3,367,315 | $93.5B | 979.80% | |
| 32 | TMOTHERMO FISHER SCIENTIFIC INC | 534,200 | $93.2B | 976.92% | |
| 33 | —AUDENTES THERAPEUTICS INC | 4,801,638 | $91.9B | 962.80% | |
| 34 | —ALLERGAN PLC | 373,590 | $90.8B | 951.91% | |
| 35 | —SHIRE PLC | 548,808 | $90.7B | 950.71% | |
| 36 | BMRNBIOMARIN PHARMACEUTICAL INC | 982,600 | $89.2B | 935.39% | |
| 37 | —MAGELLAN HEALTH INC | 1,215,100 | $88.6B | 928.48% | |
| 38 | PFEPFIZER INC | 2,458,800 | $82.6B | 865.70% | |
| 39 | UNHUNITEDHEALTH GROUP INC | 428,600 | $79.5B | 833.00% | |
| 40 | INSYEURINSYS THERAPEUTICS INC NEW | 6,171,440 | $78.1B | 818.30% | |
| 41 | MDTMEDTRONIC PLC | 879,000 | $78.0B | 817.69% | |
| 42 | —ALLERGAN PLC | 88,200 | $76.5B | 801.92% | |
| 43 | IM8NINSMED INC | 4,393,509 | $75.4B | 790.25% | |
| 44 | —MALLINCKRODT PUB LTD CO | 1,672,700 | $75.0B | 785.65% | Put |
| 45 | GKOSGLAUKOS CORP | 1,741,700 | $72.2B | 757.08% | |
| 46 | ILMNILLUMINA INC | 398,500 | $69.1B | 724.79% | |
| 47 | CRVSCORVUS PHARMACEUTICALS INC | 5,379,349 | $65.1B | 682.26% | |
| 48 | VRAYQVIEWRAY INC | 9,458,567 | $61.2B | 641.45% | |
| 49 | —ACHILLION PHARMACEUTICALS IN | 13,107,200 | $60.2B | 630.60% | |
| 50 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 2,171,935 | $59.4B | 622.64% | |
| 51 | ONCBEIGENE LTD | 1,287,588 | $57.9B | 607.32% | |
| 52 | SEMSELECT MED HLDGS CORP | 3,687,400 | $56.6B | 593.29% | |
| 53 | —GW PHARMACEUTICALS PLC | 561,071 | $56.2B | 589.57% | |
| 54 | —IMMUNOMEDICS INC | 30,000,000 | $54.8B | 574.34% | |
| 55 | HCAHCA HEALTHCARE INC | 597,400 | $52.1B | 546.03% | |
| 56 | ALNYALNYLAM PHARMACEUTICALS INC | 639,200 | $51.0B | 534.39% | |
| 57 | BMYBRISTOL MYERS SQUIBB CO | 874,700 | $48.7B | 510.86% | |
| 58 | ISRGINTUITIVE SURGICAL INC | 48,200 | $45.1B | 472.57% | |
| 59 | SYKSTRYKER CORP | 316,300 | $43.9B | 460.11% | |
| 60 | —IMMUNOMEDICS INC | 4,928,958 | $43.5B | 456.20% | |
| 61 | NTLAINTELLIA THERAPEUTICS INC | 2,662,180 | $42.6B | 446.47% | |
| 62 | —BLUEBIRD BIO INC | 399,800 | $42.0B | 440.22% | |
| 63 | —DERMIRA INC | 1,418,873 | $41.3B | 433.38% | |
| 64 | —NABRIVA THERAPEUTICS PLC | 3,919,600 | $41.1B | 430.56% | |
| 65 | NVROEURNEVRO CORP | 526,300 | $39.2B | 410.59% | Call |
| 66 | PIRSPIERIS PHARMACEUTICALS INC | 7,259,620 | $36.7B | 385.04% | |
| 67 | SELBUSDSELECTA BIOSCIENCES INC | 1,842,797 | $36.6B | 383.61% | |
| 68 | —ENVISION HEALTHCARE CORP | 578,100 | $36.2B | 379.75% | |
| 69 | —MOMENTA PHARMACEUTICALS INC | 2,109,068 | $35.6B | 373.60% | |
| 70 | EHTHEHEALTH INC | 1,834,700 | $34.5B | 361.54% | |
| 71 | —RADIUS HEALTH INC | 704,100 | $31.8B | 333.80% | |
| 72 | OTICEUROTONOMY INC | 1,559,074 | $29.4B | 308.05% | |
| 73 | IMGNEURIMMUNOGEN INC | 3,938,272 | $28.0B | 293.50% | |
| 74 | —JUNO THERAPEUTICS INC | 915,208 | $27.4B | 286.74% | |
| 75 | —STEADYMED LTD | 4,246,196 | $26.8B | 280.40% | |
| 76 | IOVAIOVANCE BIOTHERAPEUTICS INC | 3,382,900 | $25.2B | 264.17% | |
| 77 | IARTINTEGRA LIFESCIENCES HLDGS C | 426,910 | $23.3B | 243.92% | |
| 78 | —OBSEVA SA | 2,605,531 | $22.3B | 233.50% | |
| 79 | GLPGGALAPAGOS NV | 283,500 | $21.7B | 227.38% | |
| 80 | ASMBASSEMBLY BIOSCIENCES INC | 888,426 | $18.3B | 192.30% | |
| 81 | —DBV TECHNOLOGIES S A | 512,900 | $18.3B | 191.98% | |
| 82 | —IMMUNOGEN INC | 10,000,000 | $18.3B | 191.40% | |
| 83 | SVASINOVAC BIOTECH LTD | 2,667,500 | $18.0B | 188.73% | |
| 84 | TEVATEVA PHARMACEUTICAL INDS LTD | 526,300 | $17.5B | 183.26% | |
| 85 | CTIC1USDCTI BIOPHARMA CORP | 5,000,000 | $16.6B | 173.47% | |
| 86 | VNDAVANDA PHARMACEUTICALS INC | 967,859 | $15.8B | 165.36% | |
| 87 | XNCRXENCOR INC | 747,244 | $15.8B | 165.34% | |
| 88 | CHRSCOHERUS BIOSCIENCES INC | 1,079,700 | $15.5B | 162.40% | |
| 89 | —NOVUS THERAPEUTICS INC | 2,537,110 | $14.8B | 155.57% | |
| 90 | NTRANATERA INC | 1,276,190 | $13.9B | 145.27% | |
| 91 | —NEWLINK GENETICS CORP | 1,846,000 | $13.6B | 142.22% | |
| 92 | NBIXNEUROCRINE BIOSCIENCES INC | 284,841 | $13.1B | 137.34% | |
| 93 | —WRIGHT MED GROUP N V | 8,679,975 | $12.7B | 132.84% | |
| 94 | —AEGERION PHARMACEUTICALS INC | 15,000,000 | $12.3B | 128.60% | |
| 95 | PRQRPROQR THRAPEUTICS N V | 2,305,446 | $12.0B | 125.66% | |
| 96 | AUPHAURINIA PHARMACEUTICALS INC | 1,797,400 | $11.0B | 115.49% | |
| 97 | ARGXARGENX SE | 500,000 | $10.6B | 111.16% | |
| 98 | HRTXHERON THERAPEUTICS INC | 650,000 | $9.0B | 94.37% | |
| 99 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 1,914,660 | $8.6B | 90.11% | |
| 100 | AZNASTRAZENECA PLC | 250,000 | $8.5B | 89.34% | Put |
Page 1 of 2Next